UnitedHealth Group Incorporated(UNH) - Stock detail

UnitedHealth Group Incorporated

US
UNH
UnitedHealth Group Incorporated(Listing date: 10/19/1984)

UnitedHealth Group Incorporated is a Delaware corporation. It is a diversified company dedicated to helping people live healthy lives and work better. The company provides a wide range of products and services through two distinct platforms: UnitedHealthcare, which offers healthcare coverage and benefit services; and Optum, which provides information and technology-enabled health services.

AI Rating

Rating methodology
Latest close (chg%)291.96+0.95%
Buy price
291.96
Target price270.00
Sell price295.00
P/E TTM21.77
P/E21.96
Confidence70%
Risk score80/100
AI Summary
Structural margin deterioration (gross profit down 35.9% YoY), regulatory pressures (CMS enrollment suspension), technical breakdown trading 7% below 60-day MA, and leadership instability warrant capital preservation

Alpha Score

0-10
  • TrendScore 4/10

    UNH shows stabilization signs after January 27th market event with mixed technical indicators suggesting cautious optimism but remaining vulnerable below 60-day moving average.

  • ValuationScore 5/10

    Current valuation multiples appear reasonable but not compellingly cheap, with P/E of 21.77, P/B of 2.79, and P/S of 0.59 indicating potential undervaluation relative to sales. The 18% price decline from recent highs partially reflects challenges but may not fully account for ongoing margin pressures.

  • Financial strengthScore 5/10
    Mixed financial health with current ratio of 0.79 indicating potential liquidity constraints, moderate debt-to-equity of 67.15%, and strong revenue growth of 11.81% year-over-year to $447.57B.
  • ProfitabilityScore 3/10
    Profitability shows significant challenges with gross margin compression from 9.09% to 5.21% and net margin decline from 3.81% to 2.86%. Return metrics are solid but declining, with ROE at 12.51% (down from 15.88%) and ROA at 3.97%.
  • SentimentScore 2/10
    UnitedHealth Group faces significant near-term headwinds from rising health costs, margin pressure, leadership changes, and regulatory risks, creating a bearish outlook for the stock.
Latest price
$291.96+0.95%
Market cap263.93B
P/E TTM21.77
P/E21.96
Volume7.61M
Turnover2.21B